Mechanism and modification of bradykinin-induced coronary vasodilation
- PMID: 1056012
- PMCID: PMC432693
- DOI: 10.1073/pnas.72.6.2060
Mechanism and modification of bradykinin-induced coronary vasodilation
Abstract
In isolated perfused rabbit hearts, bradykinin produced a concentration-dependent decrease in coronary resistance directly associated with biosynthesis and release of prostaglandin-E-like substance. An inhibitor of bradykinin destruction (the nonapeptide SQ-20881) markedly enhanced both the coronary vasodilation and release of prostaglandin-E-like substance produced by cardiac injection of bradykinin. Indomethacin inhibited both the myocardial prostaglandin biosynthesis and the decrease in coronary resistance induced by bradykinin. The demonstration that bradykinin is a potent stimulator of prostaglandin biosynthesis in the heart has implications as to the cause of the afferent cardiovascular reflexes and pain in myocardial infarction and angina pectoris.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
